Allegra Suits Dropped After Sandoz Amends ANDAs

By Ben James

Law360, New York (February 23, 2010, 3:24 PM ET) -- Aventis Pharmaceuticals Inc. and Albany Molecular Research Inc. have dropped six patent infringement suits against Sandoz Inc. over the allergy drug Allegra, following Sandoz's amendment of two abbreviated new drug applications to seek approval for generic versions only after the applicable patents expire.

Judge Joseph A. Greenaway Jr. of the U.S. District Court for the District of New Jersey signed off Feb. 18 on a stipulation of dismissal regarding the cases.

On Jan. 8, Sandoz — the generics arm of Swiss drug giant Novartis — filed...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles